PLoS ONE · 2016 · 160 citations · 33 references
MedicineOncologyPharmacologyApoptosisCancer PharmacologyMolecular OncologyApoptosis PharmacologyApoptosis ResistanceCancer Cell SignalingOncology PharmacologyPancreatic CancerAnticancer ActivityAnticancer Natural ProductsApoptotic Signaling In CancerCancer Cell ApoptosisCancer Cell Proliferation InhibitionPhytochemical CompositionPhytochemicals In Cancer PreventionProtein Kinase Inhibitors
Pancreatic cancer is one of the most appalling cancers with a pessimistic prognosis. Despite many therapies, there has been no improvement of survival rates. In this study, we assessed the anti-cancer effects of kaempferol, a well known flavonoid having functional bio-activity against various malignant tumors. Kaempferol had anti-cancer effects on Miapaca-2, Panc-1, and SNU-213 human pancreatic cancer cells. In a dose-dependent manner, kaempferol decreased viability of these pancreatic cancer cells by increasing apoptosis. In particular, kaempferol effectively inhibited the migratory activity of human pancreatic cancer cells at relatively low dosages without any toxicity. The anti-cancer effect of kaempferol was mediated by inhibition of EGFR related Src, ERK1/2, and AKT pathways. These results collectively indicate that kaempferol, a phytochemical ingredient reported to have anti-viability and anti-oxidant properties, can act as a safety anti-migration reagent in human pancreatic cancer cells, which provide the rationale for further investigation of kaempferol as a strong candidate for the potential clinical trial of malignant pancreatic cancers.
33
TCMSP: a database of systems pharmacology for drug discovery from herbal medicines
Jinlong Ru, Peng Li, Jinan Wang et al. · Journal of Cheminformatics · 2014 · 5K citations · Full text
Jennifer Almond, K. H. Link, H. G. Beger et al. · The Lancet · 2001 · 1.1K citations